INSIGHTS ON CLINICAL TRIAL DESIGN
-
![GettyImages-2203372173-assay-wells-elisa]( "Choosing The Most Effective Method For Biopharmaceutical Development")
Choosing The Most Effective Method For Biopharmaceutical DevelopmentExplore how the application of protein assays extend from basic research to the development of cutting-edge therapies, which makes them indispensable in the quest to improve human health.
-
![GettyImages-1386486759 EDC]( "Avoid Database Go-Live Delays With The Right EDC System")
Avoid Database Go-Live Delays With The Right EDC SystemIf you are looking to speed up your start-up process, selecting a reliable EDC System is key.
-
![GettyImages-1676137801 facility design, warehouse]( "Five Ways Centralized Trial Finance Improves Site And Patient Satisfaction")
Five Ways Centralized Trial Finance Improves Site And Patient SatisfactionCentralizing payments and logistics improves transparency, accelerates reimbursements, and supports better site performance and patient retention in clinical trials.
-
![Dedicated Community Oncology Sites]( "Dedicated Community Oncology Sites")
Dedicated Community Oncology SitesRapid activation, strong referral partnerships, diverse patient access, and specialized immunotherapy infrastructure are reshaping oncology research.
-
Flexible By Design: Support For Early-Phase Oncology Trial7/8/2026
Shifting cohorts, doses, and protocols challenge early-phase oncology trials. Learn how adaptable technology keeps studies on track.
-
Winning Enrollment In A Competitive CNS Trial Landscape7/29/2026
Many CNS trials today operate in a highly competitive environment. Enrollment success is shaped by the decisions teams make under these constraints.
-
Accelerating A Schizophrenia Trial While Ensuring Quality7/31/2026
Tight timelines and rising patient targets don't have to derail a trial. See how speed and data quality can work together from enrollment to database lock.
-
The Importance Of A Maturity Model For Clinical Trial Transparency10/23/2024
A comprehensive maturity model for clinical trial disclosure and transparency offers companies a strategic tool to assess and enhance their practices in an increasingly complex regulatory environment.
-
The Secret Sauce Behind High-Enrolling PIs7/16/2026
The real challenge with enrollment often comes at the screening stage, where PI prioritization, site bandwidth, and sponsor support guide how many patients actually make it onto a study.
CLINICAL TRIAL DESIGN SOLUTIONS
-
![GettyImages-151617200-petri dish-bacteria-cells]( "Translational And Biomarker Sciences: Enabling Breakthroughs")
Learn about expert services specializing in precision medicine and biomarker-driven contract and clinical research that can assist you through translational solutions.
-
![GettyImages-1135573728-digital-patient-tablet-recruitment]( "Enhance Clinical Trial Screening And Improve Patient Matching Accuracy")
Bridge the gap between raw data and clinical enrollment. Use AI-driven insights and natural language summaries to identify the right patients faster and with greater transparency.
-
![Couple driving in car-GettyImages-1320539830]( "Integrating Lyft Pass To Increase Flexibility For Trial Participants")
Whether used for routine appointments or trial participation, Lyft Pass ensures that patients have timely access to transportation, supporting adherence to schedules and improving overall engagement.
-
![GettyImages-489341888 nurse clinical docs]( "Protocol-Driven, Customized Site Solution Strategy")
Accelerate study start-up with the right sites, patients, and partnerships
As protocols become more complex and sites face new pressures, your site selection strategy needs to be more nuanced than ever before. At Parexel, we bring that nuance and precision with the help of our Site Alliance Strategists, Community Alliance Network and Launch Excellence Office — a team who are committed to launching your projects quickly and efficiently with expertise in all key functions in clinical development strategy, planning, oversight, and delivery execution.
-
![Eye Drop iStock-1182318206]( "Comprehensive Services For Ophthalmology Drug Development")
As a leading partner in ocular therapy, Altasciences is at the forefront of ophthalmic drug development. Our integrated CRO/CDMO solutions can support your program from lead candidate selection to market.
